Literature DB >> 32479821

Filoviruses Infect Rhesus Macaque Synoviocytes in Vivo and Primary Human Synoviocytes in Vitro.

Timothy K Cooper1, James Logue2, David X Liu2, Donna L Perry2, Randy J Hart2, Amanda M W Hischak2, John G Bernbaum2, Dawn M Gerhardt2, Oscar Rojas2, J Kyle Bohannon2, Katie R Hagen2, Reed F Johnson3, Ian Crozier4, Peter B Jahrling2, Lisa E Hensley5, Richard S Bennett2.   

Abstract

The most commonly reported symptom of post-Ebola virus disease syndrome in survivors is arthralgia, yet involvement of the joints in acute or convalescent Ebola virus infection has not been well characterized in human patients or animal models. Through the use of immunohistochemistry, we found that the lining synovial intima of the stifle (knee) is a target for acute infection by Ebola virus/Kikwit, Ebola virus/Makona-C05, and Marburg virus/Angola in the rhesus macaque model. Furthermore, we found through histologic analysis, immunohistochemistry, RNAscope in situ hybridization, and transmission electron microscopy that synoviocytes of the stifle, shoulder, and hip are a target for mouse-adapted Ebola virus/Yambuku-Mayinga infection during acute disease in rhesus macaques. A time course of infection study with Ebola virus/Kikwit found large joint synovium became immunopositive beginning on postinfection day 6. In total, the synovium of 28 of 30 rhesus macaques with terminal filovirus disease had evidence of infection (64 of 96 joints examined). On the basis of immunofluorescence, infected cell types included CD68+ type A (macrophage-like) synoviocytes and CD44+ type B (fibroblast-like) synoviocytes. Cultured primary human fibroblast-like synoviocytes were permissive to infection with Ebola and Marburg viruses in vitro. Because synovial joints include immune privileged sites, these findings are significant for future investigations of filovirus pathogenesis and persistence as well as arthralgias in acute and convalescent filovirus disease.
Copyright © 2020 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32479821     DOI: 10.1016/j.ajpath.2020.05.013

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  2 in total

1.  Rhesus Macaque CODEX Multiplexed Immunohistochemistry Panel for Studying Immune Responses During Ebola Infection.

Authors:  Sizun Jiang; Nilanjan Mukherjee; Richard S Bennett; Han Chen; James Logue; Bonnie Dighero-Kemp; Jonathan R Kurtz; Ricky Adams; Darci Phillips; Christian M Schürch; Yury Goltsev; John W Hickey; Erin F McCaffrey; Alea Delmastro; Pauline Chu; J Rachel Reader; Rebekah I Keesler; José A Galván; Inti Zlobec; Koen K A Van Rompay; David X Liu; Lisa E Hensley; Garry P Nolan; David R McIlwain
Journal:  Front Immunol       Date:  2021-12-06       Impact factor: 7.561

2.  Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease.

Authors:  Robert W Cross; Zachary A Bornholdt; Abhishek N Prasad; Courtney Woolsey; Viktoriya Borisevich; Krystle N Agans; Daniel J Deer; Dafna M Abelson; Do H Kim; William S Shestowsky; Lioudmila A Campbell; Elaine Bunyan; Joan B Geisbert; Natalie S Dobias; Karla A Fenton; Danielle P Porter; Larry Zeitlin; Thomas W Geisbert
Journal:  JCI Insight       Date:  2022-05-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.